Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Cipla
AstraZeneca
Cantor Fitzgerald
Julphar
McKinsey
Farmers Insurance
Fish and Richardson
Colorcon

Generated: December 11, 2017

DrugPatentWatch Database Preview

DISULFIRAM Drug Profile

« Back to Dashboard

Which patents cover Disulfiram, and when can generic versions of Disulfiram launch?

Disulfiram is a drug marketed by Chartwell Molecules, Mylan Pharms Inc, Par Pharm, Sigmapharm Labs Llc, Watson Labs, Watson Labs Teva, West-ward Pharms Int, and Alvogen Malta. and is included in eleven NDAs.

The generic ingredient in DISULFIRAM is disulfiram. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
Drug patent expirations by year for DISULFIRAM

Pharmacology for DISULFIRAM

Medical Subject Heading (MeSH) Categories for DISULFIRAM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Chartwell MoleculesDISULFIRAMdisulfiramTABLET;ORAL091563-001Dec 31, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sigmapharm Labs LlcDISULFIRAMdisulfiramTABLET;ORAL091619-001Mar 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncDISULFIRAMdisulfiramTABLET;ORAL203916-002Mar 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson Labs TevaDISULFIRAMdisulfiramTABLET;ORAL086890-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sigmapharm Labs LlcDISULFIRAMdisulfiramTABLET;ORAL091619-002Mar 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntDISULFIRAMdisulfiramTABLET;ORAL202652-002Feb 5, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Chartwell MoleculesDISULFIRAMdisulfiramTABLET;ORAL091563-002Dec 31, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncDISULFIRAMdisulfiramTABLET;ORAL203916-001Mar 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmDISULFIRAMdisulfiramTABLET;ORAL088793-001Aug 14, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmDISULFIRAMdisulfiramTABLET;ORAL088792-001Aug 14, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
Express Scripts
McKesson
Merck
Baxter
Federal Trade Commission
Novartis
Chubb
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot